Cardiac CT software for visualization, measurement, and calcium scoring to support clinician-led cardiovascular assessment.
Clinical role
Clinical cardiac-image review, visualization, measurement, calcium scoring, and follow-up support within physician-led cardiovascular assessment.
Images and patients
CT/CTA · Heart and cardiovascular anatomy, including vessels, chambers, coronary arteries, heart valves, and great vessels such as the aorta.
Key limitation
Use the tool only within the described cardiac CT workflows. The source material does not establish a patient age group, institutional setting, or numeric clinical-performance endpoint.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?It analyzes 2D or 3D cardiac CT data for cardiovascular visualization, measurements, and calcium scoring of calcified plaque.
Which scans and anatomy are in scope?It accepts non-contrast and angiography cardiac CT DICOM data of the heart, coronary arteries, valves, chambers, and great vessels.
Who uses it?Clinicians use the software within physician-led cardiovascular assessment for image review, measurement, calcium scoring, and follow-up support.
What does the software produce?It provides calcium scores, segmentation and labeling, vessel and distance measurements, image exports, and DICOM structured-report calcium-scoring results.
What is its most important limitation?The FDA materials describe measurement and score correlation, not a numeric sensitivity, specificity, AUC, Dice score, or reader-study result for clinical performance comparison.
Clinical takeaway. CardIQ Suite supports cardiac CT visualization, measurement, and calcium scoring in clinician-led cardiovascular assessment; its outputs support rather than replace the clinical decision process.
Evidence takeaway. The FDA material reports engineering validation and high correlation between manual and automated calcium scoring. It does not provide a numeric diagnostic sensitivity, specificity, AUC, Dice, or reader-aided performance result for this version.
Additional limitations
The FDA materials describe GE AW Server operation, DICOM processing, and structured-report export, but do not establish local PACS or RIS compatibility, current security controls, training, pricing, or reimbursement.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Visualization and measurement of cardiovascular anatomy, chamber mobility, calcium scoring, and follow-up of stents, bypasses, and plaque imaging to aid diagnosis and treatment-path determination for cardiovascular disease; calcium scoring may monitor coronary calcium progression or regression and aid prognosis.
Automatic segmentation and labeling of coronary calcifications; Agatston/Janowitz 130, Volume, and Adaptive Volume calcium scores; manual scoring and editing; vessel measurements; chamber cine visualization; coronary 2D review; ROI and distance measurements; image and measurement export; and DICOM SR calcium-scoring results.
The FDA packet does not specify a patient age group, institutional care setting, or numeric clinical-performance endpoint. The described outputs aid diagnosis and treatment-path decisions; the clinical comparison reports correlation of manual and automated calcium scores, not sensitivity or specificity.
Engineering validation on retrospective CT exams passed defined acceptance criteria for calcium segmentation, labeling, and scoring. Three board-certified radiologists manually scored representative clinical images and the results were compared with CardIQ Suite automated scores; FDA reports very high correlations for total calcium score against the manual method and predicate, without numeric sensitivity, specificity, AUC, Dice, or reader-delta results.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
Engineering validation on retrospective CT exams passed defined acceptance criteria for calcium segmentation, labeling, and scoring. Three board-certified radiologists manually scored representative clinical images and the results were compared with CardIQ Suite automated scores; FDA reports very high correlations for total calcium score against the manual method and predicate, without numeric sensitivity, specificity, AUC, Dice, or reader-delta results.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
CardIQ Suite regulatory performance study summary
DesignStand-Alone Performance
PopulationPopulation described in the exact-submission ACR model card
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K213725
IndependenceIndependence not established
K213725
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K213725. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: 2D or 3D cardiac CT DICOM data from non-contrast and angiography acquisitions of the heart.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The packet describes operation on the GE AW Server, DICOM CT processing, DICOM SR export of calcium-scoring results, and saving/exporting images and measurements for referral, reporting, and archiving. Specific local PACS or RIS compatibility is not established.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. A legacy catalog deployment category, normalized to fixed categories, was not traced to the exact FDA decision document it cited, so it is not published as verified. Confirm the deployment model, hosting, data flow, and current commercial configuration with the vendor or an exact-submission source that states it.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-11-13 ·
Returned objects
Source context, not route validation: Automatic segmentation and labeling of coronary calcifications; Agatston/Janowitz 130, Volume, and Adaptive Volume calcium scores; manual scoring and editing; vessel measurements; chamber cine visualization; coronary 2D review; ROI and distance measurements; image and measurement export; and DICOM SR calcium-scoring results.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Automatic segmentation and labeling of coronary calcifications; Agatston/Janowitz 130, Volume, and Adaptive Volume calcium scores; manual scoring and editing; vessel measurements; chamber cine visualization; coronary 2D review; ROI and distance measurements; image and measurement export; and DICOM SR calcium-scoring results.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The packet describes operation on the GE AW Server, DICOM CT processing, DICOM SR export of calcium-scoring results, and saving/exporting images and measurements for referral, reporting, and archiving. Specific local PACS or RIS compatibility is not established.
ACR AI Central provides an exact-submission model card for CardIQ Suite; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-09Last searched
22Fields reviewed
9Source classes checked
0Awaiting review PubMed leads
0Awaiting review trial leads
0Unreviewed FDA recall leads
Exact-submission ACR model-card fields were normalized under the current provenance rules; vendor and independent-study confirmation remain distinct. Exact FDA scope controls clinical claims. ACR provides bounded exact-submission catalog context. Candidate literature metadata remains a discovery queue until full-text identity, endpoint, population, and version review is completed. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads remain unpublished until a human confirms the exact product and tested version.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Care setting: Not publicly available - checked 2026-11-14 - Exact FDA submission
The exact FDA decision document was reviewed on 2026-11-14 and does not state a care setting or patient population for the subject device. Confirm intended sites and patients with the vendor and local policy.
Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission
No public price or quote for the exact K213725 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not verified - checked 2026-11-13 - Exact FDA submission
A legacy catalog deployment category, normalized to fixed categories, was not traced to the exact FDA decision document it cited, so it is not published as verified. Confirm the deployment model, hosting, data flow, and current commercial configuration with the vendor or an exact-submission source that states it.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-09 - Exact FDA submission
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-09 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: AI-CVD provides automated quantitative CT-derived anatomical and density measurements for clinician review, including calcium scores, cardiac and vascular measurements, lung and liver density, bone mineral density, and muscle/fat composition; it is opportunistic decision support, not diagnostic interpretation or risk prediction.
Authorized purpose: cvi42 Coronary Plaque supports qualified professionals with viewing, post-processing, and qualitative and quantitative evaluation of adult cardiac CT DICOM images to assess the presence and extent of coronary plaques and stenoses in CCTA for CAD or suspected CAD.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.